Protective Role of R-spondin1, an Intestinal Stem Cell Growth Factor, against Radiation-Induced Gastrointestinal Syndrome in Mice by Bhanja, Payel et al.
Protective Role of R-spondin1, an Intestinal Stem Cell
Growth Factor, against Radiation-Induced
Gastrointestinal Syndrome in Mice
Payel Bhanja
1, Subhrajit Saha
1, Rafi Kabarriti
1, Laibin Liu
1, Namita Roy-Chowdhury
2,3, Jayanta Roy-
Chowdhury
2,3, Rani S. Sellers
4, Alan A. Alfieri
1, Chandan Guha
1,4*
1Department of Radiation Oncology, Albert Einstein College of Medicine, Bronx, New York, United States of America, 2Department of Medicine, Albert Einstein College of
Medicine, Bronx, New York, United States of America, 3Department of Genetics, Albert Einstein College of Medicine, Bronx, New York, United States of America,
4Department of Pathology and Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York, United States of America
Abstract
Background: Radiation-induced gastrointestinal syndrome (RIGS) results from a combination of direct cytocidal effects on
intestinal crypt and endothelial cells and subsequent loss of the mucosal barrier, resulting in electrolyte imbalance, diarrhea,
weight loss, infection and mortality. Because R-spondin1 (Rspo1) acts as a mitogenic factor for intestinal stem cells, we
hypothesized that systemic administration of Rspo1 would amplify the intestinal crypt cells and accelerate the regeneration
of the irradiated intestine, thereby, ameliorating RIGS.
Methods and Findings: Male C57Bl/6 mice received recombinant adenovirus expressing human R-spondin1 (AdRspo1) or
E.coli Lacz (AdLacz), 1–3 days before whole body irradiation (WBI) or abdominal irradiation (AIR). Post-irradiation survival
was assessed by Kaplan Meier analysis. RIGS was assessed by histological examination of intestine after hematoxilin and
eosin staining, immunohistochemical staining of BrdU incorporation, Lgr5 and b-catenin expression and TUNEL staining.
The xylose absorption test (XAT) was performed to evaluate the functional integrity of the intestinal mucosal barrier. In
order to examine the effect of R-spondin1 on tumor growth, AdRspo1 and AdLacZ was administered in the animals having
palpable tumor and then exposed to AIR. There was a significant increase in survival in AdRspo1 cohorts compared to
AdLacZ (p,0.003) controls, following WBI (10.4 Gy). Significant delay in tumor growth was observed after AIR in both
cohorts AdRspo1 and AdLacZ but AdRspo1 treated animals showed improved survival compared to AdLacZ. Histological
analysis and XAT demonstrated significant structural and functional regeneration of the intestine in irradiated animals
following AdRspo1 treatment. Immunohistochemical analysis demonstrated an increase in Lgr5+ve crypt cells and the
translocation of b-catenin from the cytosol to nucleus and upregulation of b-catenin target genes in AdRspo1-treated mice,
as compared to AdLacz-treated mice.
Conclusion: Rspo1 promoted radioprotection against RIGS and improved survival of mice exposed to WBI. The mechanism
was likely related to induction of the Wnt-b-catenin pathway and promotion of intestinal stem cell regeneration. Rspo1 has
protective effect only on normal intestinal tissue but not in tumors after AIR and thereby may increase the therapeutic ratio
of chemoradiation therapy in patients undergoing abdominal irradiation for GI malignancies.
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Introduction
Normal homeostasis of intestinal epithelium is maintained by an
intricate cell replacement process in which terminally differenti-
ated epithelial cells are continuously and rapidly replaced by
replication and differentiation of epithelial cells (transit cells)
located within the intestinal crypts. Radiation-induced gastroin-
testinal syndrome (RIGS) is due in part to the killing of clonogenic
crypt cells with eventual depopulation of the intestinal villi [1,2].
Crypt epithelial cells proliferate rapidly and are highly sensitive to
cytotoxic agents and irradiation. Loss of this regenerating
population of clonogenic cells following irradiation prevents the
normal reepithelialization of the intestinal villi. This impairment
leads to varying degrees of villous blunting and fusion, with
attenuation and hypertrophy of the villous epithelial cells [3].
These changes result in the acute RIGS presenting with
malabsorption, electrolyte imbalance, diarrhea, weight loss and
potentially death. The late side effects and the sequelae of severe
acute intestinal radiation injury include varying degrees of
intestinal inflammation, mucosal thickening, collagen deposition,
and fibrosis, as well as impairment of mucosal and motor functions
[4,5,6]
The putative multipotent, intestinal stem cell is thought to be
located at the base of the crypt, either at fourth or fifth cell position
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between Paneth cells [8]. In the normal state, these cells rarely
proliferate unless there is a pressure for increased production of the
clonogenic self-renewing progenitor cells, which undergo rapid
clonal expansion, followed by differentiation into the mature cells
lining the villi. The daughter cells migrate either toward the villus
differentiating into enterocytes, goblet cells, and enteroendocrine
cells, that are eventually shed into the gut, or inwards to the crypt
bases giving rise to Paneth cells [9]. Thus, the multipotent cells are
fundamental to the maintenance of the cell population of the
intestinal epithelium and it’s regeneration after injury [10].
Following exposure to ionizing radiation, cells located at the base
of the crypt undergo rapid apoptosis, or stop dividing temporarily
or permanently. The extent of cell loss and intestinal injury is
dependent on the radiation dose [11]. Therefore, the fate of the
crypt after injury is determined by replacement of the clonogenic
proliferating crypt cells by intestinal stem cell. If all crypt cells die,
the crypt is ‘‘sterilized’’ and disappears within 48 hours. However,
if one or more ‘clonogenic cell’ survives the insult, it rapidly
proliferates regenerating the crypt within 72–96 hours with
subsequent reconstitutions of the villi. Survival of the animal
depends on the balance between crypt depopulation, and the
efficiency and number of the surviving clonogenic cells regener-
ating the crypts.
The b-catenin/T cell factor (TCF) signal transduction pathway
plays a critical role in the regulation of proliferation and
differentiation of the intestinal epithelial cells during the
regeneration and maturation process along the crypt-villus axis
[12,13]. Wnt signaling and the activation of b-catenin are
important in the proliferation of the pluripotent stem cell that
gives rise to crypt epithelial progenitors. The amount of Wnt
proteins within the intestinal epithelial cells decreases with
progression up the villus. As Wnt signaling decreases, b-catenin
forms a complex with APC and axin (destruction complex),
leading to the degradation of b-catenin [14]. Thus Wnt signaling is
likely important to the maintenance of the undifferentiated state of
intestinal crypt progenitor cells [12,13]. Recently, a Wnt target
gene, Lg45/Gpr49, which encodes an orphan G protein-coupled
receptor, was identified as a marker of intestinal stem cells because
it marked small columnar cells at the base of the crypt interspersed
between Paneth cells [15]. Elegant lineage tracing experiments
demonstrated that these few Lgr5+ve cells could reconstitute a
villus in an adult mouse upon induction of a cre knock-in allele.
The R-spondin (roof plate-specific spondin) family of proteins is
comprised of novel secreted proteins, which acts as major agonists
and modulators of the Wnt-b-catenin signaling pathway [16,17].
There are four human paralogs (R-spondin1–4), each containing a
leading signal peptide, two cystein-rich, furin-like domains, and
one thrombospondin type 1 domain. Human Rspo1, a 29 kd, 263
amino acid protein, has a specific proliferative effect on intestinal
crypt cells [18]. Transgenic expression of Rspo1 in mice resulted
in marked hyperplasia of intestinal crypts in both small and large
intestine, resulting in abdominal distension [18]. Further exper-
iments demonstrated that Rspo1 prevented mucositis, induced by
a chemotherapeutic agent, 5-flurouracil (5-FU), in mice [18] and
more recently it was further demonstrated by the same group that
Rspo1 protected mice from chemotherapy or radiation-induced
oral mucositis [19]. In addition, systemic administration of Rspo1
decreased inflammation and reduced the loss of body weight,
diarrhea and rectal bleeding in a mouse model of dextran sulfate
sodium-induced colitis [20]. Based upon these findings, we
hypothesized that Rspo1 would be radioprotective against RIGS
and examined whether Rspo1 was involved in the recovery of the
intestine from radiation injury.
Results
Serum Rspo1 Levels Are Increased after WBI
RIGS results in part from radiation-induced DNA damage, cell
death and/or cell cycle arrest in intestinal crypt cells. Therefore,
recovery from RIGS will depend on DNA repair in surviving
irradiated crypt clonogens and regeneration of new intestinal
progenitor cells. Since Rspo1 enhances the proliferation of
intestinal crypt cells, we first examined whether the blood level
of Rspo1 is increased after WBI in mice. Immunoblot analysis
showed barely detectable levels of endogenous R-spondin1 in the
serum of untreated mice. WBI resulted in a two-fold increase in
serum Rspo1 concentrations by day 3.5 (Fig 1A and 1B). To
evaluate the effect of Rspo1 on RIGS, we injected C57Bl/6J mice
with 5610
9 particles of AdRspo1 prior to WBI (Fig 1A). Serum
Rspo1 expression increased 6–8 fold in 2 to 3.5 days after
AdRspo1 administration and persisted at that level for at least 1
week (Fig 1C). Mice injected with similar doses of the control
adenovirus, AdLacZ showed no increase over the base line levels
of Rspo1.
AdRspo1 Improves Survival of Mice after WBI and AIR
In most mammals, including mice, a total-body radiation
exposure of more than 10 Gy results in a characteristic
gastrointestinal syndrome comprising diarrhea, weight loss and
death within 5–14 days [29]. We administered escalating doses of
WBI to C57Bl/6J mice to induce RIGS. Exposure to 8.4, 9.4 and
10.4 Gy was lethal in 0%, 20% and 100% of the mice within 14
days, respectively. As the 10.4 Gy dose was uniformly lethal, we
administered this dose of WBI to the AdRspo1- and AdLacZ-
treated groups to evaluate the radioprotective effects of Rspo1.
Figure 1. Time course evaluation of serum Rspo1 expression.
(A) Treatment schema: AdRspo1 or AdLacZ (5610
9 pu) was injected
intravenously 3 and 1 day before WBI (10.4 Gy) in C57Bl/6 mice. Animals
were followed for survival and histological endpoints. (B) Immunoblots
of murine serum demonstrating time course evaluation of serum Rspo1
expression after WBI. (C) Representative immunoblot of serum Rspo1
levels in C57Bl/6 mice, following treatment with AdRspo1 + WBI.
doi:10.1371/journal.pone.0008014.g001
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7 days. In contrast, AdRspo1-treated animals had well-formed
stools and maintained body weight after WBI (23.260.5 g,
AdRspo1 versus 17.2661.2 g in AdLacZ-treated cohorts;
p,0.0002). AdRspo1 improved survival of animals exposed to
10.4 Gy WBI significantly (p,0.003), with an improvement in
median survival time from 1061.4 days in AdLacZ treated
animals to 2761.6 days in AdRspo1-treated animals. During the
first two weeks after WBI, approximately 30% of the animals died
in the AdRspo1-treated group, compared with 100% mortality in
AdLacZ-treated animals, indicating that Rspo1 protected these
animals from RIGS (Fig 2A). The delayed mortality (after 25 days)
in the AdRspo1-treated animals was interpreted to be the result of
radiation-induced hematopoeitic syndrome. AdRspo1, when
administered after the mice were exposed to WBI, could not
mitigate the lethal effects of WBI (data not shown).
Since the effects of WBI of 10.4 Gy are secondary to combined
hematopoeitic and gastrointestinal syndrome, we wanted to induce
primarily a radiation-induced gastro-intestinal injury in mice. We,
therefore, administered escalating doses of whole AIR after
shielding the thorax, head and neck and extremities, thus
protecting the bone marrow. A single fraction of 12, 14 or 16
Gy of AIR was lethal in 100% of mice treated with PBS or AdLcZ
by 2 weeks. In contrast, animals treated with AIR + AdRspo1 had
well-formed stools and maintained body weight (21.960.8,
AdRspo1 versus 16.460.3 g in AdLacZ-treated cohorts;
p,0.0001) with only 10% and 30% animals dead at 2 weeks
after 12 and 14 Gy of AIR, respectively. There was significant
improvement in survival in AdRspo1-treated mice to AIR doses
up to 14 Gy (p,0.002) (Fig. 2B). There was no radioprotection by
AdRspo1 in mice receiving 16Gy AIR.
AdRspo1 Does Not Protect Tumors from Cytotoxic Effects
of AIR
In order to examine whether AdRspo1 could protect tumors
from radiation, Balb/c mice with palpable, murine colorectal,
CT26 flank tumors were injected with either AdLacz or AdRspo1
virus, followed by 14 Gy AIR, 3 days after viral injection.
AdRspo1 did not delay tumor growth compared to AdLacz. As
expected, there was significant delay in tumor growth and
improved survival only in AdRspo1-treated animals (median
survival time 2662 days) after AIR (Fig 3). Although, AIR reduced
tumor growth (p,0.0001) but invariably produced 100%
mortality of AdLacZ-treated animals. These results demonstrate
that Rspo1 could increase the therapeutic ratio of radiation
therapy for the treatment of abdominal tumors where it would
increase the tolerance of the intestine to irradiation without
providing radioprotection to the tumor.
AdRspo1 Augments Intestinal Crypt Epithelial Cell
Proliferation after WBI
Radiation doses of $8 Gy induces cell cycle arrest and apoptosis
of the crypt epithelial cells within day 1 post-radiation, leading to
crypt depletion and a decrease in regenerating crypt colonies by
day 3.5 and ultimately villi denudation by day 7 post-radiation
exposure [23]. We, therefore, evaluated the histological manifes-
tation of RIGS and the effect of AdRspo1 on RIGS at 1, 3.5 and 7
days, post-WBI. First, we examined whether Rspo1 induces the
proliferation of crypt stem cells in mice receiving WBI. As seen in
Fig 4, BrdU-labeling cells were vastly amplified in the crypts of
AdRspo1+WBI-treated mice, compared to Ad-LacZ+WBI-treated
controls at 1 and 3.5 days post-WBI. The percentage of the crypt
epithelial cells synthesizing DNA was significantly enhanced after
AdRspo1, treatment compared with those administered AdLacZ
(AdRspo1, 3562.27.versus AdLacZ, 2262.04; P,0.05) at 3.5
days following WBI (Fig. 5B). This resulted in an increase in the
overall size of the crypts, as determined by measuring crypt depth
from the base of the crypt to the crypt-villus junction (Fig. 4 and
5A). A significant increase in the crypt depth in AdRspo1-treated
mice compared with AdLacZ-treated mice (AdRspo1,
98.565.6 mm versus AdLacZ, 5263.8 mm; p,0.001) was ob-
served, indicating an amplification of the crypt cells after AdRspo1
treatment in irradiated mice (Fig. 4 and 5A). Finally, the intestine
in WBI+AdRspo1-treated animals was much longer than those of
WBI+AdLacZ-treated animals (38.4860.9 cm AdRspo1 vs.
33.3661.1 cm, AdLacZ; p,0.002).
Effect of AdRspo1 on Intestinal Crypt Cell Apoptosis after
Radiation Injury
Since ionizing radiation induces apoptosis of intestinal crypt
epithelial cells, we performed TUNEL assay to examine apoptosis
of crypt epithelial cells, 1 day after WBI. There was a significant
(p,0.001) decrease in the number of apoptotic nuclei in the
jejunal crypts of AdRspo1-treated animals (1761.2) as compared
with the AdLacZ-treated (26.561.4) controls (Fig. 4 and 5C),
suggesting that Rspo1 might increase the radioresistance of the
Figure 2. AdRspo1 treatment protected C57Bl/6 mice from radiation-induced mortality. Kaplan-Meier survival of C57Bl/6 mice treated
with AdRspo1 or AdLacZ prior to WBI (10.4Gy) (Fig 2A) and 12–16 Gy AIR (Fig 2B) . Note a significant (p,0.003) increase in median survival in
AdRspo1-treated mice with a median survival time of 2761.6 days, compared to AdLacZ cohorts, 1061.4 days. With 12–14Gy AIR median survival
time for AdLacZ treated animals is 1361.2 and 1161.6 days compared to 2561.3 and 1961.4 in AdRspo1-treated animals.
doi:10.1371/journal.pone.0008014.g002
R-spo1 Protects against RIGS
PLoS ONE | www.plosone.org 3 November 2009 | Volume 4 | Issue 11 | e8014intestinal crypt compartment by decreasing radiation-induced
apoptosis.
Crypt Microcolony Assay
Radiation-induced apoptosis of crypt epithelial cells induces
compensatory proliferation of intestinal stem cells and transit
amplifying cells, resulting in crypt regeneration and clonal growth
of damaged intestinal villi. The number of regenerating crypts
forming microcolonies between days 3 and 4 after WBI, is a
surrogate indicator of the resistance of the intestine to WBI and is
correlated with the survival of animals from RIGS. We, therefore,
counted the number of regenerative crypts per unit area of
intestinal cross section, 3.5 days after exposure to WBI, according
to protocols originally described by Withers and Elkind [26]. The
number of crypt microcolonies was increased significantly in
AdRspo1-treated mouse intestines compared with AdLacZ
controls (AdRspo1, 13.860.7/mm versus AdLacZ, 8.260.5,
p,0.001, Fig 5D), indicating that Rspo1 induced intestinal crypt
regeneration after exposure to WBI.
AdRspo1 Ameliorates Intestinal Malabsorption Syndrome
in RIGS
To evaluate the functional regeneration and absorptive capacity
of the intestine, animals from various treatment cohorts were fed
xylose solution following exposure to WBI. Since xylose is not
metabolized in the body, serum xylose levels are a good indicator of
theintestinalabsorptivecapacity.Asexpected,therewasaconsistent
reduction in xylose absorption in AdLacZ-treated mice (33.567.5
g/ml), 7 days after WBI. In contrast, there was a significant recovery
of xylose absorption in AdRspo1-treated mice (7563.8 g/ml;
p,0.002)atthistimepoint.Xyloseabsorptioncontinuedtoimprove
in the AdRspo-1 treated animals up to 10 days post-WBI (Fig. 6),
indicating quick restitution of the intestinal villi.
b-Catenin Localization in Nuclear and Cytosolic Fraction
Recent reports indicate that the R-spondin proteins activate b-
catenin signaling [20,30], which is critical in maintaining intestinal
homeostasis [13]. Under resting condition, b-catenin is present in
the cytoplasm. Phosphorylation of b-catenin (by GSK-3 kinase)
targets the proteins to to proteosomes where it is degraded. Wnt
activation inhibits GSK-3 kinase phosphorylation of b-catenin,
preventing b-catenin degradation and allowing for its translocation
from the cytoplasm to the nucleus. In the nucleus, b-catenin binds
to and activates the TCF/LEF transcription factor complex to
induce the expression of wnt-pathway genes, such as, EphB2,
EphB3, TCF4 and LEF1. We, therefore, examined the relative
levels of b-catenin protein in the cytoplasm and nucleus of
intestinal epithelial cells isolated from the two cohorts of animals
that received WBI. Immunoblot analysis demonstrated a slight
increase in nuclear b-catenin levels, 1 day after WBI in AdLacZ-
treated mice (Fig 7A). In contrast, the nuclear/cytosolic ratio of b-
catenin was much higher in Ad-Rspo1-treated mice in basal
conditions (day –1, Fig 7B), which further increased by 2–4 folds
the value of AdLacZ-treated animals, with a peak around 3.5 days
upon exposure to WBI (Fig 7A and B). Immunohistochemistry
confirmed an increase in nucelar b-catenin staining in the crypt
progenitor cells in AdRspo1-treated animals, suggesting that
Rspo1 enhanced stabilization and nuclear translocation of b-
catenin in crypt cells in these animals (data not shown).
AdRspo1 Amplifies the Number of Lgr5-Positive Crypt
Stem Cells
Immunohistochemical staining of murine jejunum crypts
showed a significant increase in the number of Lgr5-expressing
intestinal stem cells at crypt columnar base in the AdRspo1-treated
mice (Fig. 8). Three and a half days after exposure to WBI, while
the Lgr5+ve crypt stem cells decreased in AdLacZ-treated mice,
these cells remain amplified in AdRspo1-treated mice, suggesting
an expansion of the crypt stem cell compartment contributed to
the protection from RIGS.
Real Time PCR of the Expression of b-Catenin Target
Genes
The expression of target genes of the b-catenin pathway in these
animals was determined by realtime PCR. The mRNA levels of
Figure 4. Histolological assessment of intestine after Irradia-
tion. H&E staining demonstrates increased crypt depth and increased
villi thickness in AdRspo1-treated animals following exposure to WBI.
BrdU immunohistochemistry demonstrates higher crypt cell prolifera-
tion after AdRspo1 treatment when compared to AdLacZ cohorts.
Finally, TUNEL staining demonstrates a decrease in the rate of TUNEL-
positive, apoptotic cells in AdRspo1-treated mice post-WBI, when
compared to intestinal lumen of AdLacZ-treated mice.
doi:10.1371/journal.pone.0008014.g004
Figure 3. AdRspo1 treatment has no effect on tumor growth.
Effect of AdRspo1 and AdLacZ treatment on tumor growth rate of Balb/
c mice (n=5) irradiated with 14Gy ABI. Significant delay in tumor
growth (p,0.0001) was observed in ABI groups (Fig A) compared to
untreated mice.
doi:10.1371/journal.pone.0008014.g003
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4.8 fold, respectively in AdRspo1-treated animals exposed to WBI,
as compared with AdLacZ-treated cohorts. The mRNA levels of
the b-catenin target genes, TCF4 and Lef1 were also upregulated
approximately 2.5 fold in response to Rspo1 after irradiation while
the expression of TCF1 and TCF3 were unchanged.
Discussion
The gastro-intestinal (GI) system is a major target for the
somatic injuries associated with radiation and chemotherapy.
Because of this, RIGS is an important cause of host vulnerability
whether in medical therapeutics or in nuclear accidents or
terrorism. Rspo1 was originally identified as a growth factor for
intestinal crypt cells in a mouse transgenic model [18]. In a mouse
xenograft model of human colon carcinoma, CT26, treatment
with Rspo1 reduced the mucositis, diarrhea and weight loss caused
by the chemotherapeutic agent, 5-flurouracil (5-FU), without
affecting its antitumor effect [18]. Furthermore, systemic admin-
istration of Rspo1 decreased the histological and clinical
manifestation of dextran sulfate sodium-induced colitis [20] and
chemotherapy and radiation-induced oral mucositis [19] in mice.
These data suggested that Rspo1 might play an important role in
maintaining intestinal mucosal integrity.
Zhao et al demonstrated that prophylactic treatment with
recombinant RSpo1 protein increased the mucosal thickness and
reduced ulceration in the oral mucosa after irradiation and
chemotherapy, presumably by increasing the proliferation of the
mucosal epithelium in the basal layer of the tongue [19].
Figure 5. AdRspo1 increases the number of regenerative crypts in irradiated mice. Effect of AdRspo1 and AdLacZ treatment on intestinal
crypt depth (A), proliferation rate (B), apoptotic cells (C) at 1day and 3.5 days after WBI and the number of regenerative crypts (D) at 3.5 days after
WBI. A representative sampling of thirty crypts was assessed for each treatment group.
doi:10.1371/journal.pone.0008014.g005
Figure 6. Xylose absorption assay. A time course study (1–10dys)
showed significant recovery (p,0.002) of xylose absorption at 3.5 to
7 days in AdRspo1-treated cohorts, when compared to AdLacZ controls,
thereby indicating the functional regeneration of intestine after
radiation injury. AdLacZ-treated animals were incapable of demonstrat-
ing adequate xylose absorption after radiation injury, further contrib-
uting to animal mortality.
doi:10.1371/journal.pone.0008014.g006
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the effect of Rspo1 in the functional regeneration of the intestinal
mucosal epithelium and amelioration of RIGS has not been
studied. In this report, we demonstrate that Rspo1 is induced after
exposure to WBI as a physiological response to irradiation
exposure. Systemic administration of an adenovirus expressing
recombinant Rspo1 amplified the Lgr5+ve intestinal crypt stem
cell population and ameliorated RIGS and improved survival of
mice. The effect of AdRspo1 on the regeneration of the intestinal
mucosa after irradiation was manifested physically by significantly
higher intestinal length and diameter, increased crypt depth and
proliferative index, decreased crypt epithelial apoptosis, increased
regenerative crypt microcolonies and maintenance of the villi
length. This improved clinical, gross, and histopathological effects
on the small intestine after WBI and AIR in AdRspo1-treated
mice were physiologically manifested by a marked and progressive
restoration of the normal absorptive function of the intestine, as
measured by xylose absorption test.
R-spondins are a family of secreted proteins that are expressed
in the small intestine, kidney, prostate, adrenal gland and pancreas
Figure 7. AdRspo1 treatment induces b-catenin activation in irradiated crypts. Representative immunoblot (Fig. 7A) and densitometric
analysis (Fig. 7B) of nuclear/cytosolic ratios of b-catenin from AdRspo1 and AdLacZ treated cohorts after WBI(10.4Gy). Nuclear fraction purity was
validated by the absence of b-tubulin, while the purity of the cytosolic fraction was evaluated by the absence of PCNA (Fig. 7A). A continuous decline
in nucear/cytosolic ratios of b-catenin was predominate in samples from irradiated AdLacZ cohorts. This is further supported by the densitometric
analysis of b-catenin expression (Fig. 7B) from the nuclear/cytosolic ratio demonstrating the significant differences in AdRspo1 when compared to
AdLacZ treated mice prior to (Day –1) until Day +5 post WBI.
doi:10.1371/journal.pone.0008014.g007
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Rspo1 has been demonstrated to bind with high affinity to the Wnt
co-receptor, LRP6, to induce phosphorylation, stabilization and
nuclear translocation of cytosolic b-catenin, thereby activating
TCF/b-catenin-dependent transcriptional responses in intestinal
crypt cells [32]. Our results suggest that the induction of Rspo1
after TBI may be an important protective pathway in the repair of
intestinal injury in RIGS. In our experiments, Rspo1 could not
prevent the mortality of the animals from the hematopoeitic
syndrome, since all animals receiving WBI + AdRSpo1 were dead
by 25–28 days. However, Rspo1 protected the death from GI
syndrome, even with higher doses of AIR (12–14 Gy). Rspo1 likely
promotes protection of RIGS through a combination of reduced
radiation-induced apoptosis (i.e. increased cell survival), increased
crypt cell proliferation with enhanced crypt regeneration, and
rapid restoration of the structure and absorptive function of the
villi. On a cellular level, AdRspo1 treatment increased the levels of
nuclear b-catenin and wnt target gene expression in irradiated
crypt cells. Notable among the wnt target genes that are induced in
AdRspo1-treated animals are Tcf4 and Lef1, two genes that are
responsible for intestinal epithelial cell proliferation and mainte-
nance of homeostasis. Similarly, EphB2 and EphB3 are induced
and could mediate crypt cell proliferation, differentiation and cell
positioning along the crypt villus axis, following WBI. Further-
more, the number of Lgr5+ve crypt base columnar cells,
resembling the intestinal stem cells as described by Cheng and
Leblond [8], was amplified in AdRspo1+WBI-treated mice. These
data, in conjunction with the histological findings of an increase in
crypt regeneration and improved intestinal restitution after WBI in
mice treated with AdRspo1, as compared to AdLacZ, indicates
that Rspo1 mediates induction of an intestinal regenerative
process, possibly as a salvage mechanism, following exposure to
WBI. Furthermore, compared with AdLacZ-treated controls,
pretreatment with AdRspo1 reduced WBI-associated intestinal
crypt cell apoptosis. Since the wnt/b-catenin signaling has been
postulated to promote radioresistance of mammary epithelial stem
cells [33], Rspo1 might also confer radioprotection to crypt
progenitor cells by stimulating Wnt-b-catenin signaling in RIGS.
Several growth factors and cytokines including KGF, TGFbeta,
TNFa, PGE2, IL11 [34,35,36,37] have been shown to protect
intestine from radiation or other cytotoxic injury by increasing the
crypt cell proliferation and survival. While growth factors, such as,
bFGF could minimize the radiation induced intestinal damage by
reducing apoptosis [38,39]. To our knowledge, this is the first
demonstration of the salutary effect of Rspo1 in the context of
radiation injury of the intestine where it played a protective role by
amplifying the stem cell population along with inhibition of
radiation induced apoptosis in crypt. Since, Rspo1 has no
protective effect on tumors during chemotherapy [18] and
radiation therapy (Fig 3), systemic use of Rspo1, by protecting
the normal intestinal tissue, may increase the therapeutic ratio of
chemoradiation therapy in patients undergoing abdominal
irradiation for GI malignancies. While the mechanism(s) associ-
ated with preserving structural regeneration and function ensures
the potential prophylactic and salvage role of hRspo1 in rescuing
the absorptive capacity of intestine, further studies are warranted
to evaluate its potential as a therapy for RIGS in combination with
other mitigating agents by reversing radiation-induced injury of
the intestine.
Materials and Methods
Animals
Five- to 6-weeks-old male C57Bl/6 mice (NCI-Fort Dietrich,
MD) were maintained in the animal maintenance facilities and all
animal studies were performed under the guidelines and protocols
of the Institutional Animal Care and Use Committee of the Albert
Einstein College of Medicine.
Adenovirus Construction and Administration
Since recombinant Rspo1 was not available to us, we
constructed an adenovirus (AdRspo1) expressing human R-
spondin1 protein and used adenoviral gene transfer for proof-of-
concept experiments. Human R-spondin1 cDNA (Origene,
Rockville, MD) was subcloned in pShuttle-2 (Clonetech, Mountain
View, CA), followed by ligation into the Adeno-X viral DNA
according to protocols described in the Adeno-XTM expression
system (Clonetech, Mountain View, CA). The recombinant
adenoviral vector was linearized with Pac-1 and transfected in
293 kidney cells (ATCC, Manassas, VA) using Lipofectamine plus
(Invitrogen, Carlsbad, CA), according to the manufacturer’s
protocol until a cytopathetic effect (CPE) appeared. 293 cells
were cultured in Dulbecco’s Modified Eagle’s medium (DMEM)
(Invitrogen, Carlsbad, CA) supplemented with 10% heat-inacti-
vated fetal bovine serum (FBS) (Atlanta Biologicals, Lawrenceville,
Ga), and supplemented with 0.1 mM nonessential amino acids
(Invitrogen, Carlsbad, CA), 100 mg/ml streptomycin (Invitrogen,
Carlsbad, CA) and 100 units/ml penicillin (Invitrogen, Carlsbad,
CA). Viral lysates were amplified and subjected to CsCl2 gradient
centrifugation to purify the recombinant AdRspo1 adenovirus as
described[21]. The adenovirus expressing the ß-galactosidase gene
of E. coli (AdLacZ) was used as a control adenovirus in these
experiments. All viruses were stored as 5610
10 particles/ml of
glycerol buffer.
5610
9 particles of AdRspo1 or AdLacZ (adenovirus expressing
b-galactosidase gene of E. coli as control) were injected intravenously
via tail vein, 1–2 times at 3 and/or 1 day before whole body
irradiation (WBI). Viral lysates were amplified and subjected to
Figure 8. AdRspo1 treatment increases the number of Lgr5-
positive intestinal stem cells in irradiated crypts. Immunohisto-
chemical staining of Lgr5 in murine jejunum crypts at 3.5 days prior and
after WBI. There was an increase in the number of Lgr5 postive cells at
crypt columnar base in AdRspo1 treated cohorts when compared to
AdLacZ (magnification 60x; arrows).
doi:10.1371/journal.pone.0008014.g008
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adenovirus as described elsewhere [21,22]. All viruses were stored
as 5610
10 particles/ml of glycerol buffer.
Irradiation Procedure
Whole-body irradiation (WBI) was performed on anesthetized
mice (intraperitoneal ketamine and xylazine 7:1 mg/ml for 100 l/
mouse) using a Shephard
137Cs -ray irradiator at a dose rate of
236cGy/min following biosafety guidelines of Albert Einstein
College of Medicine. Initially a dose response (8–10.4 Gy) of WBI
demonstrated that C57Bl/6 mice receiving 10.4 Gy died within
two weeks, suggesting death from RIGS. Thereafter, protection
experiments with AdRspo1 were performed with 10.4 Gy. Since
10.4 Gy WBI can induce both hematopoeitic and gastrointestinal
injury, we also administered escalating doses (12–16 Gy) of whole
abdominal irradiation (AIR) after shielding the thorax, head and
neck and extremities and protecting a significant portion of the
bone marrow, thus inducing predominantly RIGS.
Irradiation of Abdominal Tumors
Balb/c mice were injected with 1610
6 CT26 colon cancer cells
(ATCC, Manassas, VA) on the flank. Ten days after tumor
inoculation, animals with palpable tumors received an intravenous
injection of AdRspo1 (1610
11 particles), followed by whole AIR of
14Gy by Mark I
137 Cs source a day later.
Detection of Rspo1 Expression in Blood
Blood was drawn from the retro-orbital plexus and serum was
isolated by centrifugation at 10,000 rpm for 5 min. Serum protein
concentration was determined by Bradford assay kit (Bio-Rad
Laboratories, Hercules, CA). Approximately 100 mg of protein
was subjected to 14% SDS-PAGE, followed by electroblotting
onto polyvinylidene difluoride membranes. The blot was blocked
with 5% skim milk in Tris-buffered saline (10 mM Tris-HCl
(pH 7.4), 150 mM NaCl, 0.05% Tween 20) followed by
incubation with primary antibody (1:200 dilution), goat polyclonal
anti mouse Rspo1 (R & D Systems, Minneapolis, MN), and then
with secondary antibody (1:500 dilution), horseradish peroxidase
(HRP) conjugated bovine anti-goat antibody (Santa-Cruz Bio-
technology, Inc., Santa Cruz, CA). The blots were developed using
Enhanced Chemiluminence assay (Amersham Pharmacia Biotech,
Inc, Piscataway, NJ).
Histology
Since radiation doses greater than 8 Gy induces cell cycle arrest
and apoptosis of the crypt epithelial cells within day 1 post-
radiation, resulting in a decrease in regenerating crypt colonies by
day 3.5 and ultimately villi denudation by day 7 post-radiation
exposure [23], we sacrificed animals when moribund or at 1, 3.5
and 7 days after WBI or AIR for time course experiments and
intestine were harvested for histology. The intestine of each animal
was dissected, washed in PBS to remove intestinal contents and the
jejunum was fixed in 10% neutral buffered formalin prior to
paraffin embedding. Tissue was routinely processed and cut into
5 mm sections for hematoxylin and eosin and immunohistochemical
staining. All haemotoxylin and eosin (Fisher Scientific, Pittsburgh,
PA) staining was performed at the Histology and Comparative
Pathology Facility in the Albert Einstein Cancer Center. A total of
30 crypts were examined per animal for all histological parameters.
Crypt Proliferation Rate
To visualize villous cell proliferation, each mouse was injected
intraperitoneally with 120 mg/kg BrdU (Sigma-Aldrich, USA) 2–
4 hrs prior to sacrifice and mid-jejunum was harvested for paraffin
embedding and BrdU immunohistochemistry. Tissue sections
were routinely deparaffinized and rehydrated through graded
alcohols and incubated overnight at room temperature with a
biotinylated monoclonal BrdU antibody (Zymed, South Francisco,
CA). Nuclear staining was visualized using Streptavidin-peroxidase
and diaminobenzidine (DAB) and samples were lightly counter-
stained with hematoxylin. Jejunum from mice, not injected with
BrdU, was used as a negative control. Murine crypts were
identified histologically according to the criteria established by
Potten et al [24]. Digital photographs of crypts were taken at high
(400–600X) magnification (Zeiss AxioHOME microscope) and
crypt epithelial cells (paneth and non-paneth) intestinal sections
were examined using ImageJ software and classified as BrdU
positive if they grossly demonstrated brown-stained nuclei from
DAB staining or as BrdU negative if they were blue stained nuclei.
The proliferation rate was calculated as the percentage of BrdU
positive cells over the total number of cells in each crypt.
Determination of Crypt Depth
Crypt depth was independently and objectively analyzed and
quantitated in a blind fashion from coded digital photographs of
crypts from H&E stained slides using ImageJ 1.37 software to
measure the height in pixels from the bottom of the crypt to the
crypt-villus junction. This measurement in pixels was converted to
length (in mm) by dividing with the following a conversion factor
(1.46 pixels/mm).
Detection of Apoptosis In Situ
Apoptotic cells were detected in situ by performing TUNEL
(TdT–mediated digoxigenin labeled dUTP nick end labeling)
staining. Briefly, paraffin embedded sections were de-paraffinized,
rehydrated through graded alcohols and stained using an
ApopTag kit (Intregen Co, Norcross, Georgia). The apoptotic
rate in crypt cells was quantified by counting the percent of
apoptotic cells in each crypt with analysis restricted to ‘‘intact’’
longitudinal crypt sections in which the base of the crypt was
aligned with all the other crypt bases and the lumen [3,24].
In Vivo Crypt Microcolony Survival Assay
Intestinal crypt survival was measured using a modification of
microcolony assay [25,26]. A regenerative crypt comprised of
tightly compacted and occasionally multi-layered large epithelial
cells with a highly basophilic cytoplasm and large nuclei. The
viability of each surviving crypt was confirmed by immunohisto-
chemical detection of BrdU incorporation into five or more
epithelial cells within each regenerative crypt. A minimum of four
complete cross-sections was scored for each mouse and represen-
tative kinetic data were obtained from two mice in each group.
Because the size of the regenerating crypt may not be the same for
each treatment group, the number of surviving crypt per cross
section was normalized to crypt size. Surviving crypts were defined
as containing 10 or more adjacent chromophilic non-Paneth cells,
a Paneth cell and lumen [25].
Immunohistochemistry
For immunohistochemical staining of formalin-fixed, paraffin-
embedded tissue sections, endogenous peroxidase activity was
blocked for 30 min with methanol containing 0.3% H2O2. Antigen
retrieval was performed by heating slides in pH 6.0 citrate buffer
at 100uC for 20 min in a microwave oven at 500 watts. Non-
specific antibody binding was blocked for 20 minutes by
incubation with 10% normal rabbit serum. Sections were
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diluted 1:200, and Lgr5 diluted 1:250 (Transduction Laboratories,
Lexington, KY), either 1 hr at room temperature or overnight at
4uC. The primary antibody was visualized using a streptavidin-
biotin-peroxidase (ABC) kit (DAKO, Carpinteria, CA) with
diaminobenzidine tetrahydrochloride (3,39-diaminobenzidine) as
the chromogen. These sections were then lightly couterstained by
haematoxylin (Fisher Scientific, Pittsburg, PA).
Isolation of Intestinal Epithelial Cells
Intestinal epithelial cells were prepared from the jejunum of adult
male C57Bl6 mice by modification of the protocol described by
Weiser and Ferraris [27]. Briefly, mice were anaesthetized and a
catheter was inserted into the intestine through an incision in the
most proximal part of duodenum. A second incision was made just
proximal to the cecum and the entire small intestine was perfused
with ice-cold PBS and then flushed twice with ice-cold PBS plus 1
mM dithiothreitol (DTT). The duodenum and ileum were
discarded and the entire jejunum was tied at the distal end and
filled to distension with isolation citrate buffer (0.9% NaCl, 1.5 mM
KCl, 27.0 mM Na Citrate, 8.0 mM KH2PO4 and 5.6 mM
Na2HPO4, pH 7.3) heated to 37uC for 15 mins. After incubation,
thejejunumwasemptiedand filledwith 5 mlethylenediamine tetra
acetic acid (EDTA) buffer (0.9% NaCl, 8 mM KH2PO4, 5.6 mM
Na2HPO4, 1.5 mM Na2-EDTA, pH 7.6, plus 0.5 mM DTT and
0.23 mM PMSF) (Sigma Aldrich, St. Louis, MO). Each jejunum
was then physically manipulated and tapped allowing the cells to
separate from the interior surface. The jejunum was finally rinsed
twice with 5 ml of EDTA buffer and all the fluid containing
epithelial cellswascollected,centrifuged at 3006g (SorvellRc5c) for
5 min, washed twice with 20 mL of balanced salt solution (BSS)
containing 135 mM NaCl, 4.5 mM KCl, 5.6 mM glucose, 0.5 mM
MgCl2, 10 mM HEPES and 1.0 mM CaCl2, pH 7.4, and the cells
suspended in 2 mL of the same solution. Cell numbers were
determined with hemocytometer and viABIlity (.9065%) was
assessed using trypan blue exclusion.
Detection of b-Catenin Expression in Intestinal Cells by
Immunoblot
Intestinal epithelial cells were isolated from the jejunum of
AdRspo1- and AdLacZ-treated mice by modification of the
protocol described by Weiser and Ferraris [27] as described in
supplement. Isolated cells were fractionated as cytosolic and
nuclear part by Nuclear/Cytosol Fractionation kit (Biovision
Incorporated, Mountain View, California), according to the
manufacturer’s protocol and then subjected to immunoblot to
analyze the b-catenin expression using mouse monoclonal
antibody b-catenin (BD Bioscience, San Jose, CA). The immuno-
blot was developed and signal was detected by Chemiluminance
assay (Amersham Pharmacia Biotech Inc, Piscataway, NJ). Purity
of nuclear and cytosolic fractions was determined by the relative
absence of b-tubulin and PCNA, respectively.
RNA Isolation
Isolated murine intestinal epithelial cells were lysed using RLT
buffer from RNeasy Mini Kit (Qiagen, Valencia, CA) and 1%
betamercaptoethanol mix. Qiagen’s protocol for the RNeasy Mini
Kit with on-column DNA digestion was used to isolate RNA from
the lysates. The RNA samples were stored at 280uC prior to use.
Realtime PCR of b-Catenin Target Genes
To analyze the involvement of b-catenin downstream pathway
in Rspo1 mediated intestinal repair mRNA levels of different b-
catenin target genes in intestinal epithelial cells from from
AdRspo1 and AdLacZ treated mice before and after WBI (10.4
Gy) were analyzed by real time PCR. cDNA was synthesized using
the SuperScript
TM First-Strand Synthesis System from Invitrogen.
Realtime PCR was performed in Light Cycler real time PCR
machine (Bio Rad Laboratories, Hercules, CA) using the ABsolute
QPCR SYBER Green Mix (ABgene, Rochester, USA). The
conditions followed the standard ABgene protocol with the
exception for the annealing and extension step, where a
temperature of 55uC for EphB2 and EphB3, 57uC for Tcf4, and
54uC for Lef1 were used for 30 seconds followed by 30 seconds at
72uC. To check for primer amplification specificity, a melting
curve was generated at the end of the PCR and different samples
containing the same primer pair showed matching amplicon
melting temperatures. The gene sequences of b-catenin target
genes were obtained from the Ensembl mouse genome database
(http://www.ensembl.org/Mus_musculus/index.html) and the
primers were designed using Primer3 software (http://frodo.wi.
mit.edu/cgi-bin/primer3/primer3_www.cgi). Any primer pair
generated with Primer3 was checked for gene specificity using
the nucleotide-nucleotide BLAST database (http://130.14.29.
110/BLAST/). The primer pairs used were as follows:
Beta actin: sense primer 59 TGTACCCAGGCATTGCTGAC
39 and anti-sense primer 59 ACAGTGAGGCCAGGATGGAG 39;
Ephb2: Sense primer 59 AAGATGGGCCAGTACAAGGA 39
and anti-sense primer 59 CCAGCTAGAGTGACCCCAAC 39;
Ephb3: sense primer 59 TGGGACGGTACAAGGAGAAC 39
and anti-sense primer 59 TCATGTCCTGAATGCTGCTC 39;
Tcf4: sense primer 59 GGCGTTGGACAGATCACC 39 and
anti-sense primer 59 GGTGAAGTGTTCATTGCTGTACTG 39;
Lef1: sense primer 59 AGACACCCTCCAGCTCCTGA 39
and anti-sense primer 59 CCTGAATCCACCCGTGATG 39.
Xylose Absorption Assay
To quantify intestinal absorption as a physiological indicator of
mucosal barrier integrity in AdRspo1-, and AdLacZ-treated mice
(n=5/group) after WBI, a xylose uptake assay was performed, at
various time points (1, 3.5, 7 and 10 days) after irradiation. A 5%
w/v solution of D-xylose (100l/mouse) in deionized water was
administered orally by feeding tube and 2 hrs post administration
of D-xylose animals were sacrificed and blood samples collected
using heparinized blood collection tubes (BD Biosciences, San
Jose, CA). For determination of plasma D-xylose concentration a
modified micromethod as reported by Eberts et al. was used [28].
One mL phloroglucinol (1,3,5-trihydroxybenzene, Sigma Chem-
ical Co., St. Louis, MO) reagent (0.5 g of phloroglucinol, 100 mL
glacial acetic acid and 100 mL of conc. HCL) was added to 10L of
plasma. This solution was heated to 100uC in a water bath for 4
min to allow optimum color development. After equilibration to
room temperature, sample absorption was determined with the aid
of a spectrophotometer set at a wavelength of 554 nm.
Kaplan-Meier Survival Curve Analysis
The effect of irradiation and concomitant Rspo1 on mice
survival/mortality was analyzed by kaplan-Meier as a function of
radiation (WBI and/or AIR) dose using Sigma–Plot and
Graphpad Prism-4.0 software for Mac.
Statistical Analysis of Digital Images
Sampling regions were chosen at random for digital acquisi-
tion for data quantitation. Digital image data was evaluated in a
blinded fashion as to any treatment. A total of thirty to sixty
crypts from two mice/treatment group were used for each data
point. A two-sided student’s t-test was used to determine
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mice (P,0.05) with representative standard errors of the mean
(SEM).
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